Listen "NOAC Monotherapy Wins in Afib with Drug Eluting Stents: Safer, Stronger, Smarter ⚖️🔥🧠"
Episode Synopsis
📢 ADAPT AF-DES Trial — A Safer Path Forward! In patients with atrial fibrillation beyond 1 year after drug-eluting stent implantation, NOAC monotherapy delivered striking benefits over combination therapy. ✅ Lower net adverse clinical events ✅ Marked reduction in major/CRNM bleeding ✅ Similar ischemic protection A beautifully simple strategy with meaningful impact. Published in NEJM (2025). 💊🛡️📉💓
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.